Adaptive Biotechnologies Corporation (ADPT) stock analysis

In our weekly check, Adaptive Biotechnologies Corporation is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 2, red flags: 10.

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ADPT.

What our checks show for ADPT

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-04

Similar companies

IONS · TVTX · EWTX · COGT · DFTX · TNGX

Questions

What grade does Adaptive Biotechnologies Corporation (ADPT) have?

In our weekly check, Adaptive Biotechnologies Corporation is graded D (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 2, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ADPT stock?

This week's biggest flags for Adaptive Biotechnologies Corporation: High debt, Weak interest cover, Weak EPS growth. In total 12 of 22 checks show a warning or a red flag.

What does Adaptive Biotechnologies Corporation do?

Adaptive Biotechnologies Corporation is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as ADPT.

When does Adaptive Biotechnologies Corporation report earnings next?

The next earnings report is expected on 2027-02-04. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis